181 results on '"Egeberg, Alexander"'
Search Results
2. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study
3. Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
4. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
5. Drug Survival of Biologics in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis
6. Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
7. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study
8. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study
9. Risk of systemic infections in adults with atopic dermatitis: A nationwide cohort study
10. Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis
11. Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis
12. Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
13. The risk of COVID-19 in patients with psoriasis: A retrospective cohort study
14. Machine learning model for predicting outcomes of biologic therapy in psoriasis
15. 33763 Diagnostic delay in Danish psoriasis patients
16. 33124 Severe infections, confirmed extended major adverse cardiovascular events, and malignancies over 5 years of treatment with tildrakizumab in terms of number needed to harm: Pooled analyses from the reSURFACE 1 and reSURFACE 2 phase 3 trials
17. 33566 Early response with ixekizumab predicts long-term outcomes up to 5 years in psoriasis by unsupervised and supervised machine learning analyses
18. 33108 Ixekizumab achieved and sustained nail psoriasis resolution regardless of disease severity through 5 years: Results from Uncover-3
19. 33659 Incidence of severe and rare infections among adult patients with psoriasis in Denmark
20. Cause-specific mortality in adults with atopic dermatitis
21. Prevalence and risk of migraine in patients with rosacea: A population-based cohort study
22. Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasis
23. The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
24. Association between psoriasis and asthma among United States adults in the 2009-2014 National Health and Nutrition Examination Survey
25. Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional study
26. Reply to “Correspondence to ‘Association between psoriasis and asthma among United States adults in the 2009-2014 National Health and Nutrition Examination Survey’”
27. The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events
28. Increased risk of migraine in patients with psoriasis: A Danish nationwide cohort study
29. Autoimmune diseases in adults with atopic dermatitis
30. 52793 Usage of digital information technologies in patients with hidradenitis suppurativa.
31. 52089 Patient characteristics associated with prescription of omalizumab at first visit among hospital outpatients with chronic urticaria.
32. 51843 Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa: results from the 700 first patients of the Copenhagen Hidradenitis Suppurativa Cohort Study.
33. 51561 The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with disease severity, asthma and rhinitis.
34. 51826 PRO-C22 - A Novel Serological Biomarker of Tissue Damage is Associated with Disease Severity, Disease Activity, and Systemic Inflammation in Patients with Hidradenitis Suppurativa.
35. 51791 Guselkumab improves psoriatic skin and HRQoL outcomes across BMI subgroups, including patients with involvement of hard-to-treat areas: results from the real-world PERSIST study.
36. 51783 A novel biomarker of type VII collagen degradation is increased in patients with atopic dermatitis and lowered when receiving immunosuppressant treatment.
37. 25442 Relationship between topical corticosteroid utilization and atopic dermatitis severity and burden: A population-based cross-sectional study
38. 26592 Characterization of response clusters identified by unsupervised machine learning: A post hoc analysis of the head-to-head ECLIPSE trial of guselkumab and secukinumab in patients with moderate-to-severe psoriasis
39. Prevalence of psoriasis among adults in the US 2009-2010 and 2013-2014 National Health and Nutrition Examination Surveys
40. 41176 Psoriasis And Mental Health Comorbidities: A Multinational Analysis Using the Global Healthcare Study on Psoriasis (GHSP)
41. 42892 Correlation between DLQI and PASI in patients with psoriasis - a cross-sectional Global Healthcare Study on Psoriasis (GHSP)
42. 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
43. 42592 Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
44. 44115 Integrated Safety Analysis of Abrocitinib in 3802 Patients With Moderate-To-Severe Atopic Dermatitis With Over 5000 Patient-Years of Exposure
45. 41915 Improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata achieving scalp hair regrowth: results from two randomized controlled trials
46. 42070 Comparison of COVID-19 Vaccination Rates Among Psoriasis Patients Globally Using the Global Healthcare Study on Psoriasis (GHSP)
47. Clustering of autoimmune diseases in patients with rosacea
48. Chronologic order of appearance of immune-mediated inflammatory diseases relative to diagnosis of psoriasis
49. Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis
50. Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.